Delivery Order SPE2DE21D0017-SPE2D625F0DN8
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,600 fixed-price delivery order with economic price adjustment on October 28, 2025, for COVID-19 virus test kits (Kit ID NOW COVID-19 VIR TST 24 TST). The contract is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by November 6, 2025, with performance based in Lockhart, Florida. This delivery order was awarded on a full and open basis without set-aside...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on July 14, 2025, for COVID-19 test kits under contract number 4568782066. The contract is a fixed-price delivery order with economic price adjustment provisions and will be performed in Lockhart, Florida, with an ultimate completion date of July 23, 2025. The award was made without set-aside designation, indicating open competition. Funding is provided through the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400 delivery order (Contract No. 4569814561) for COVID-19 test kits on October 24, 2025, with an ultimate completion date of November 4, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and is performed in Lockhart, Florida. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, which is a defense-oriented federal agency...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 28, 2025, for COVID-19 test kits with a ceiling value of $2,400.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of May 7, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain, operating under...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,600.00 on September 9, 2025, for COVID-19 test kits under contract 4569386625. The contract utilizes fixed-price pricing with economic price adjustment and has an ultimate completion date of September 18, 2025. Performance will occur in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding source is the Defense...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 5, 2025, for COVID-19 test kits valued at $15,000.00 with a completion date of September 16, 2025. This fixed-price contract with economic price adjustment clauses was awarded without set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain funded this award, and performance will be completed in Lockhart, Florida. The delivery order...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400.00 delivery order by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, for COVID-19 virus test kits (KIT ID NOW COVID-19 VIR TST 24 TST). The contract utilizes fixed-price pricing with economic price adjustment provisions and is scheduled for completion by October 31, 2025. Performance will be conducted at the company's location in Lockhart, Florida. This delivery order was...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 17, 2025, for COVID-19 diagnostic test kits under contract 4569502136. The order, valued at $3,600.00 with a fixed-price contract type that includes economic price adjustment provisions, is scheduled for completion by September 26, 2025. The products will be delivered to Lockhart, Florida, and the award was made by the Defense Logistics Agency Medical Supply Chain without a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on September 18, 2025, for COVID-19 test kits to support the Defense Logistics Agency Medical Supply Chain. The contract, designated as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of September 29, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostics, was awarded a $6,000 fixed-price delivery order for ID NOW COVID-19 virus test kits by the Defense Logistics Agency Medical Supply Chain on September 11, 2025. The delivery order, which has no set-aside designation, indicates open competition and carries an ultimate completion date of September 19, 2025. The performance location is identified as Lockhart, Florida. This award represents a...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F0DN8Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $4,800.00 fixed-price delivery order with economic price adjustment on June 2, 2025, for COVID-19 virus test kits (KIT ID NOW COVID-19 VIR TST 24 TST). The contract, which carries no set-aside designation indicating open competition, is scheduled for ultimate completion on June 10, 2025, and will be performed in Lockhart, Florida. Funding is provided by the Defense Logistics Agency's Medical Supply Chain, a defense-focused entity responsible for procuring medical supplies to support federal healthcare operations across military and veteran healthcare systems. This delivery order represents a continuation of Abbott Rapid DX's established role as a critical supplier of diagnostic testing solutions to federal agencies. The company maintains multiple Indefinite Delivery Vehicles with the Department of Veterans Affairs across various Integrated Service Networks, with contract values supporting ongoing COVID-19 testing and point-of-care diagnostic needs. The relatively modest ceiling value of this particular order reflects routine procurement activities under established blanket purchase agreements and supply contracts that enable federal agencies to efficiently access COVID-19 diagnostic products for continued testing capabilities within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 6/2/25 |